DI FRANCESCO, JACOPO COSIMO
 Distribuzione geografica
Continente #
NA - Nord America 6.910
EU - Europa 3.455
AS - Asia 2.998
SA - Sud America 544
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 5
Totale 13.975
Nazione #
US - Stati Uniti d'America 6.751
SG - Singapore 1.131
CN - Cina 818
DE - Germania 724
IT - Italia 644
RU - Federazione Russa 523
BR - Brasile 447
HK - Hong Kong 439
SE - Svezia 393
IE - Irlanda 283
GB - Regno Unito 220
VN - Vietnam 220
FI - Finlandia 174
UA - Ucraina 168
CA - Canada 118
IN - India 86
FR - Francia 77
AT - Austria 51
TR - Turchia 47
JP - Giappone 39
AR - Argentina 38
ID - Indonesia 36
KR - Corea 32
PL - Polonia 32
BE - Belgio 31
ZA - Sudafrica 31
DK - Danimarca 30
BD - Bangladesh 27
ES - Italia 25
NL - Olanda 25
IQ - Iraq 23
MX - Messico 23
EC - Ecuador 18
CL - Cile 14
PK - Pakistan 13
UZ - Uzbekistan 13
IR - Iran 12
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
VE - Venezuela 9
SA - Arabia Saudita 8
EU - Europa 7
LT - Lituania 7
PY - Paraguay 7
DO - Repubblica Dominicana 6
MA - Marocco 6
GE - Georgia 5
PT - Portogallo 5
AL - Albania 4
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
IL - Israele 4
PH - Filippine 4
RO - Romania 4
AU - Australia 3
BH - Bahrain 3
BO - Bolivia 3
CO - Colombia 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
NG - Nigeria 3
NI - Nicaragua 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
GR - Grecia 2
JM - Giamaica 2
KW - Kuwait 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
MU - Mauritius 2
NO - Norvegia 2
NP - Nepal 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
BS - Bahamas 1
CR - Costa Rica 1
ET - Etiopia 1
GD - Grenada 1
HN - Honduras 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MN - Mongolia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SC - Seychelles 1
Totale 13.971
Città #
Ann Arbor 1.487
Singapore 769
Ashburn 616
Hong Kong 437
Chandler 410
Fairfield 392
Woodbridge 392
Frankfurt am Main 373
Wilmington 340
Dublin 274
Houston 264
Milan 225
New York 195
Santa Clara 195
Jacksonville 176
Munich 174
Dearborn 160
Beijing 159
Seattle 154
Cambridge 132
Los Angeles 121
Princeton 114
Helsinki 110
Dallas 98
Nanjing 80
Shanghai 66
São Paulo 61
Hefei 54
Buffalo 53
Moscow 53
Ho Chi Minh City 52
Lawrence 47
The Dalles 41
Chicago 40
Hanoi 40
Altamura 38
Dong Ket 37
Vienna 35
Jakarta 30
Lachine 30
Council Bluffs 29
Seoul 28
Boardman 26
Guangzhou 26
Brooklyn 25
Nuremberg 25
Brussels 24
Denver 24
Tokyo 23
Warsaw 23
Andover 22
Jinan 22
London 22
Ottawa 22
Grafing 21
Montreal 21
Monza 21
San Diego 20
Nanchang 19
Pune 19
Toronto 19
Boston 18
Fremont 18
Johannesburg 18
Orem 18
Rome 17
Stockholm 17
Changsha 16
Zhengzhou 16
Shenyang 15
Tianjin 15
Ankara 14
Kocaeli 14
Phoenix 14
Columbus 13
Poplar 13
Rio de Janeiro 13
Santiago 13
Tashkent 13
Turku 13
Atlanta 12
Falls Church 12
Manchester 12
Salt Lake City 12
Hebei 11
Chennai 10
Hangzhou 10
Lissone 10
Curitiba 9
Edmonton 9
Jyväskylä 9
Leawood 9
Mexico City 9
Monmouth Junction 9
San Francisco 9
Guayaquil 8
Haiphong 8
Jiaxing 8
Mountain View 8
Baghdad 7
Totale 9.484
Nome #
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies 454
Cardiac and neuronal HCN channelopathies 429
TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy 403
Effect of the ketogenic diet in excitable tissues 373
Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): Candidate biomarker for immunotherapy in Alzheimer's disease and cerebral amyloid angiopathy 372
Clinical, biological and neuroradiological evolution of Cerebral Amyloid Angiopathy-related inflammation: the iCAβ International Network longitudinal study. 367
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 352
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 317
Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease 316
Generation and validation of algorithms to identify subjects with dementia using administrative data 311
Progressive epileptic encephalopathy associated with a novel HCN2 mutation 307
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 288
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 284
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 279
Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study 277
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 262
Cerebellar hematoma in a carrier of the A3243G MELAS mutation 259
Prodromal Alzheimer's Disease Presenting as Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Amyloid-Related Imaging Abnormalities and High Cerebrospinal Fluid Anti-Aβ Autoantibodies 259
Do the functional properties of HCN1 mutants correlate with the clinical features in epileptic patients? 259
Novel neurofibromatosis type 2 mutation presenting with status epilepticus 255
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 250
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-A beta auto-antibodies 249
Brain targets: can you believe your own eyes? 237
Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation 231
Cerebral Amyloid Angiopathy-Related Inflammation 230
A case of Leber hereditary optic neuropathy plus dystonia caused by G14459A mitochondrial mutation 224
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report 217
Huntington's disease and HDACi: Would sulpiride and valproate be of therapeutic value? 216
HCN1 novel mutations in familiar generalized epilepsy 214
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 214
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome 214
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 206
Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 205
Long-term risk of chronic epilepsy in adults after post-anoxic coma and refractory status epilepticus: A retrospective cohort study 204
MELAS mitochondrial DNA mutation A3243G reduces glutamate transport in cybrids cell lines 201
HCN1 mutation spectrum: From neonatal epileptic encephalopathy to benign generalized epilepsy and beyond 197
COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease 197
Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes 195
Autoimmune encephalopathy in Graves' disease: Remission after total thyroidectomy 194
Cerebral amyloid angiopathy-related inflammation: an emerging disease 194
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet 189
Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review 188
Discovering the Italian phenotype of cerebral amyloid angiopathy (CAA): the SENECA project 188
Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network 184
Adult-Onset Epilepsy in Presymptomatic Alzheimer's Disease: A Retrospective Study 183
Neurological soft signs are increased in migraine without aura: relationship with the affective status 183
Epilptic seizures and psychogenic non-epileptic seizures 182
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 181
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 179
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 176
Epilepsy in Cerebral Amyloid Angiopathy: an observational retrospective study of a large population 172
Anti-Aß autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 172
Association of Microglial Activation With Spontaneous ARIA-E and Cerebrospinal Fluid Levels of Anti-Aβ Autoantibodies 170
A loss-of-function HCN4 mutation associated with familial benign myoclonic epilepsy in infancy causes increased neuronal excitability 166
Recessive loss-of-function mutation in the pacemaker HCN2 channel causing increased neuronal excitability in a patient with idiopathic generalized epilepsy 156
Complicanze neurologiche di malattie internistiche 155
Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult Therapeutic Management 152
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-Aβ auto-antibodie 152
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 140
The management of epilepsy in clinical practice: Do the timing and severity of the disease influence the priorities of patients and the caring physicians? Data from the EPINEEDS study 140
Anti-AB autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's disease Biomarkers Collaborative Network 138
LATE-ONSET EPILEPSY WITH UNKNOWN ETIOLOGY: A PILOT STUDY ON NEUROPSYCHOLOGICAL PROFILE, CEREBROSPINAL FLUID BIOMARKERS, AND QUANTITATIVE EEG CHARACTERISTICS 132
Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy 132
Totale 14.522
Categoria #
all - tutte 46.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.017 0 0 0 0 0 140 147 174 147 151 109 149
2021/20221.015 119 111 115 84 84 94 34 46 50 48 78 152
2022/20231.695 162 472 158 188 124 237 34 82 167 11 25 35
2023/20241.056 27 62 49 69 152 257 162 56 78 11 17 116
2024/20252.687 135 283 156 97 216 180 250 153 280 388 211 338
2025/20263.240 722 295 481 837 843 62 0 0 0 0 0 0
Totale 14.522